The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $69.86

Today's change+0.35 +0.51%
Updated September 22 11:43 AM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $69.86

Today's change+0.35 +0.51%
Updated September 22 11:43 AM EDT. Delayed by at least 15 minutes.

DexCom Inc up (U.S.)$0.35

DexCom Inc is up today by (U.S.)$0.35 or 0.51% to (U.S.)$69.86. Shares have lost 0.62% over the last five days, but have gained 17.01% over the last year to date. This security has underperformed the S&P 500 by 40.50% during the last year.

Key company metrics

  • Open(U.S.) $69.72
  • Previous close(U.S.) $69.50
  • High(U.S.) $70.26
  • Low(U.S.) $69.10
  • Bid / Ask(U.S.) $69.79 / (U.S.) $69.86
  • YTD % change+17.01%
  • Volume256,150
  • Average volume (10-day)988,311
  • Average volume (1-month)1,069,430
  • Average volume (3-month)1,137,596
  • 52-week range(U.S.) $57.68 to (U.S.) $94.79
  • Beta0.39
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.77
Updated September 22 11:43 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue171142171149
Total other revenue--------
Total revenue171142171149
Gross profit11894117101
Total cost of revenue53485548
Total operating expense184183177167
Selling / general / administrative86867976
Research & development45484444
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-14-40-6-19
Interest income (expense), net non-operating-3-100
Gain (loss) on sale of assets--------
Other--------
Income before tax-14-40-7-19
Income after tax3-42-7-19
Income tax, total-17100
Net income3-42-7-19
Total adjustments to net income--------
Net income before extra. items3-42-7-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3-42-7-19
Inc. avail. to common incl. extra. items3-42-7-19
Diluted net income3-42-7-19
Dilution adjustment--0----
Diluted weighted average shares86858584
Diluted EPS excluding extraordinary itemsvalue per share0.03-0.49-0.09-0.22
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.03-0.49-0.09-0.22